SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.66+2.8%Jan 30 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (7958)12/6/1998 8:31:00 PM
From: Robert S.  Read Replies (2) of 17367
 
Cacaito, your insights and opinions are always welcomed and appreciated. I often find your posts informative but it is my opinion that your enthusiasm, as an investor, has clouded your objectivity, as a scientist.

Robert S maybe should politely look beyond the abstracts of his persistently
mentioned "reviews" so He could show that BPI is or is not one of the failure
molecules mentioned in the again "reviews".


You have insinuated, once again, that a review is less worthy than an original study; while this oftentimes may be true, it is by no means absolute. Conversely, an original study does not guarantee the quality of the research. I disagree with your outlook and addressed this issue in an earlier post:

Message 6246744

Furthermore, a plethora of reviews, forum presentations, editorials, etc., which presented BPI in a positive light, elicited no voice of protest from you; thus, I believe it is reasonable for me to conclude that you "want to have it both ways."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext